Lifecore Biomedical, Inc. · NASDAQ:LFCR
22NW Fund, LP reported a 11.10% stake in Lifecore Biomedical, Inc. (Schedule 13D/A)
Event Dec 23, 2024 · Filed Dec 26, 2024
22NW Fund, LP reported a 11.10% stake in Lifecore Biomedical, Inc., 4,367,499 shares, with active intent on Dec 23, 2024. Filed Dec 26, 2024 (Schedule 13D/A).
- Stake
- 11.10%
- Shares
- 4,367,499
- Intent
- Active
- What changed
- Stake changed
- Filed together
- 7 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| 22NW Fund, LP | 11.10% | 4,367,499 |
| 22NW, LP | 11.10% | 4,367,499 |
| 22NW Fund GP, LLC | 11.10% | 4,367,499 |
| 22NW GP, Inc. | 11.10% | 4,367,499 |
| Aron R. English | 11.10% | 4,367,499 |
| Bryson O. Hirai-Hadley | 0% | 583 |
| Nathaniel Calloway | 0% | 34,315 |
Source
Related
- Lifecore Biomedical, Inc.
- 22NW Fund, LP
- Lifecore Biomedical, Inc. shareholders
- Schedule 13D/A · 22NW Fund, LP · Jul 2, 2026
- Schedule 13D/A · 22NW Fund, LP · May 29, 2025
- Schedule 13D/A · Nelson Obus · Sep 29, 2026
- Schedule 13D/A · Legion Partners Asset Management, LLC · Sep 28, 2026
- Schedule 13G · BlackRock, Inc. · Jul 29, 2026
- Schedule 13D/A · Legion Partners Asset Management, LLC · Jul 2, 2026
- Form 4 · Legion Partners, L.P. I · Jun 8, 2026